← Back to headlines
Capricor sets deramiocel PDUFA date for August 2026, targets 2,500 patients annually
Capricor Therapeutics has announced an August 22, 2026, PDUFA date for its drug deramiocel. The company aims for a manufacturing capacity to treat 2,000 to 2,500 patients per year.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
